These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6834499)

  • 1. Pelvic lymph node status as predictor of extracapsular tumor extension in clinical stage B prostatic cancer.
    Catalona WJ; Fleischmann J; Menon M
    J Urol; 1983 Feb; 129(2):327-9. PubMed ID: 6834499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radical prostatectomy for stage B2 prostatic cancer.
    Middleton RG; Smith JA
    J Urol; 1982 Apr; 127(4):702-3. PubMed ID: 7069834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pelvic lymph node metastasis from prostatic cancer: influence of tumor grade and stage in 452 consecutive patients.
    Smith JA; Seaman JP; Gleidman JB; Middleton RG
    J Urol; 1983 Aug; 130(2):290-2. PubMed ID: 6876275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pelvic lymphadenectomy for the staging of apparently localized prostatic cancer.
    Wilson CS; Dahl DS; Middleton RG
    J Urol; 1977 Feb; 117(2):197-8. PubMed ID: 833967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphometric and clinical studies on 68 consecutive radical prostatectomies.
    Stamey TA; McNeal JE; Freiha FS; Redwine E
    J Urol; 1988 Jun; 139(6):1235-41. PubMed ID: 3373594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pitfalls in preoperative staging in prostate cancer.
    Mukamel E; Hanna J; deKernion JB
    Urology; 1987 Oct; 30(4):318-21. PubMed ID: 3660522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical outcome of radical prostatectomy and pelvic lymph node dissection].
    Mizutani K; Ono Y; Kato N; Takeda A; Yamada S; Kinukawa T; Hattori R; Sahashi M; Matsuura O; Takeuchi N
    Hinyokika Kiyo; 1995 Nov; 41(11):867-71. PubMed ID: 8533688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of lymph node counts on the detection of pelvic lymph node metastasis in prostate cancer.
    Barth PJ; Gerharz EW; Ramaswamy A; Riedmiller H
    Pathol Res Pract; 1999; 195(9):633-6. PubMed ID: 10507083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should a positive surgical margin following radical prostatectomy be pathological stage T2 or T3? Results from the SEARCH database.
    Freedland SJ; Aronson W; Presti JC; Kane CJ; Terris MK; Elashoff D; Amling CL;
    J Urol; 2003 Jun; 169(6):2142-6. PubMed ID: 12771736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel staging tool for localized prostate cancer: a pilot study using genetic adaptive neural networks.
    Tewari A; Narayan P
    J Urol; 1998 Aug; 160(2):430-6. PubMed ID: 9679892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indication for and extension of pelvic lymph node dissection during robot-assisted radical prostatectomy: an analysis of five European institutions.
    Suardi N; Larcher A; Haese A; Ficarra V; Govorov A; Buffi NM; Walz J; Rocco B; Borghesi M; Steuber T; Pini G; Briganti A; Mottrie AM; Guazzoni G; Montorsi F; Pushkar D; Van Der Poel H;
    Eur Urol; 2014 Oct; 66(4):635-43. PubMed ID: 24411992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis.
    Heidenreich A; Varga Z; Von Knobloch R
    J Urol; 2002 Apr; 167(4):1681-6. PubMed ID: 11912387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early stage prostatic cancer investigated by pelvic lymph node biopsy and bone marrow acid phosphatase.
    Sadlowski RW
    J Urol; 1978 Jan; 119(1):89-93. PubMed ID: 621824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical treatment of locally advanced (T3) prostatic carcinoma: early results.
    Bosch RJ; Kurth KH; Schroeder FH
    J Urol; 1987 Oct; 138(4):816-22. PubMed ID: 3656537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. External validation of the updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection.
    Gacci M; Schiavina R; Lanciotti M; Masieri L; Serni S; Vagnoni V; Abdollah F; Carini M; Martorana G; Montorsi F
    Urol Int; 2013; 90(3):277-82. PubMed ID: 23296120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Staging accuracy of magnetic resonance imaging versus transrectal ultrasound in stages A and B prostatic cancer.
    Vapnek JM; Hricak H; Shinohara K; Popovich M; Carroll P
    Urol Int; 1994; 53(4):191-5. PubMed ID: 7855937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The incidence and extent of pelvic lymph node metastases in apparently localized prostatic cancer.
    Fowler JE; Whitmore WF
    Cancer; 1981 Jun; 47(12):2941-5. PubMed ID: 7260881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes for Patients with Clinical Lymphadenopathy Treated with Radical Prostatectomy.
    Moschini M; Briganti A; Murphy CR; Bianchi M; Gandaglia G; Montorsi F; Quevedo JF; Carlson R; Kwon E; Karnes RJ
    Eur Urol; 2016 Feb; 69(2):193-6. PubMed ID: 26264160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Indications for pelvic lymphadenectomy in clinically localized prostate cancer].
    Peneau M; Villers A; Molinié V; Theis D; Soulié M
    Prog Urol; 2004 Jun; 14(3):287-94. PubMed ID: 15373168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limited value of perineural invasion in radical prostatectomy specimens as a predictor of biochemical recurrence in Japanese men with clinically localized prostate cancer.
    Miyake H; Sakai I; Harada K; Eto H; Hara I
    Hinyokika Kiyo; 2005 Apr; 51(4):241-6. PubMed ID: 15912782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.